Dolly A. Vance
Overview
Dolly A. Vance received an average of $1M in total compensation, including $496K in salary, at Rigel Pharmaceuticals from 2014 to 2020.
2020Rigel PharmaceuticalsExecutive Vice President, Corporate Affairs, General
2019Rigel PharmaceuticalsExecutive Vice President, Corporate Affairs, General
2018Rigel PharmaceuticalsExecutive Vice President, Corporate Affairs, General Counsel and Corporate Secretary
2017Rigel PharmaceuticalsExecutive Vice President, Corporate Affairs, General Counsel and Corporate Secretary
2016Rigel PharmaceuticalsExecutive Vice President, Corporate Affairs, General Counsel and Corporate Secretary
2015Rigel PharmaceuticalsExecutive Vice President, Corporate Affairs, General Counsel and Corporate Secretary
2014Rigel PharmaceuticalsExecutive Vice President, Corporate Affairs, General Counsel and Corporate Secretary
Source: SEC filings on April 6, 2021, April 1, 2020, April 9, 2019, April 4, 2018, and March 29, 2017.
Related executives
We found 12 more executives who work or worked at Rigel Pharmaceuticals.
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
Dean Schorno
Rigel Pharmaceuticals
Chief Financial Officer
David Santos
Rigel Pharmaceuticals
Executive Vice President and Chief Commercial Officer
Wolfgang Dummer
Rigel Pharmaceuticals
Chief Medical Officer
Anne-Marie Duliege
Rigel Pharmaceuticals
Chief Medical Officer
Eldon Mayer
Rigel Pharmaceuticals
Executive Vice President, Chief Commercial Officer
Esteban Masuda
Rigel Pharmaceuticals
Executive Vice President, Research
Ryan Maynard
Rigel Pharmaceuticals